Mark Stanley Berger Genprex, Inc. (GNPX) insider trading activity

Mark Stanley Berger is Chief Medical Officer of Genprex, Inc.. Currently has a direct ownership of 28,860 shares of GNPX, which is worth approximately $126,406. The most recent transaction as insider was on Dec 22, 2025, when has been sold 28,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K

60.59% 3M change

25.17% 12M change

Total Value Held $126,406

Mark Stanley Berger Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 22 2025	BUY Grant, award, or other acquisition	-	28,500 Added 49.69%	28,860 Common Stock
Jun 30 2025	SELL Payment of exercise price or tax liability	$1,035 $0.23 p/Share	4,500 Reduced 20.03%	17,971 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$239 $0.41 p/Share	585 Reduced 2.54%	22,471 Common Stock
Dec 05 2024	BUY Grant, award, or other acquisition	-	18,250 Added 44.18%	23,056 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$5,803 $4.4 p/Share	1,319 Reduced 21.53%	4,806 Common Stock
Feb 18 2023	BUY Grant, award, or other acquisition	-	245,000 Added 50.0%	245,000 Common Stock

Also insider at

ATNM

Actinium Pharmaceuticals, Inc. Healthcare

Chief Medical Officer

MSB